Skip to main content
Clinical Trials/NCT04753385
NCT04753385
Terminated
Not Applicable

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

LivaNova33 sites in 1 country138 target enrollmentMarch 23, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Treatment Resistant Depression
Sponsor
LivaNova
Enrollment
138
Locations
33
Primary Endpoint
Percentage of Voice Diary tasks
Status
Terminated
Last Updated
last year

Overview

Brief Summary

The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).

Detailed Description

A prospective, observational, exploratory study collecting passive and active behavioral, environmental and physiological data, via the use of an Android smartphone application and Study Watch. This sub-study is only open to sites participating in the RECOVER clinical study. All subjects participating in the RECOVER clinical trial at active UNCOVER sites will be offered participation in this sub-study. Subjects who opt-in to the Mood App portion of the sub-study will be followed for a minimum of 12 months and a maximum of 60 months for the Mood App portion of the sub-study. Subjects who opt-in to the use of the Study Watch portion of the sub-study will be followed for a minimum of 12 months and maximum of 24 months for the Study Watch portion of the sub-study.

Registry
clinicaltrials.gov
Start Date
March 23, 2021
End Date
September 6, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
LivaNova
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All Subjects
  • Current consented subject in the RECOVER clinical trial;
  • Adult (i.e. ≥ 18 years of age, unless a resident of any U.S. state where the age of majority is 19, in which case must be ≥ 19 years of age);
  • Able and willing to provide written informed consent for this sub-study;
  • Able and willing to comply with all study procedures;
  • Able to read and speak English.
  • Phone Application
  • Have a personal Google user account or be willing to create and own a personal Google user account;
  • Owns a personal Android smartphone with a data plan and is the sole user of that smartphone;
  • Agrees to download and maintain the phone application onto personal Android smartphone for the duration of the sub-study;

Exclusion Criteria

  • All Subjects
  • Any condition or situation the Principal Investigator determines as inappropriate for study inclusion
  • Phone Application
  • No additional exclusion criteria for phone application
  • Study Watch
  • Subjects with known severe allergy to nickel or metal jewelry

Outcomes

Primary Outcomes

Percentage of Voice Diary tasks

Time Frame: Through study completion; Average 2 years

Percentage of Voice Diary tasks completed over the duration of the study

Number of ping sensor recordings

Time Frame: Through study completion; Average 2 years

Number of ping sensor recordings over the duration of the study

Number of hours of watch wear time

Time Frame: Through study completion; Average 2 years

Number of hours of watch wear time over the duration of the study

Percentage of PHQ-8 tasks

Time Frame: Through study completion; Average 2 years

Percentage of PHQ-8 tasks completed over the duration of the study

Study Sites (33)

Loading locations...

Similar Trials